Neuroprotective role of quercetin in locomotor activities and cholinergic neurotransmission in rats experimentally demyelinated with ethidium bromide

Life Sciences

Volumn 103, Issue 2, 2014, Pages 79-87

  Beckmann, Diego V ^a   Carvalho, Fabiano B ^a   Mazzanti, Cinthia M ^a   Dos Santos, Rosmarini P ^a   Andrades, Amanda O ^a   Aiello, Graciane ^a   Rippilinger, Angel ^a   Graça, Dominguita L ^a   Abdalla, Fátima H ^a   Oliveira, Lizielle S ^a   Gutierres, Jessié M ^a   Schetinger, Maria Rosa C ^a   Mazzanti, Alexandre ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Acetylcholinesterase; Demyelination; Locomotor activity; Quercetin; Remyelination

Indexed keywords

ACETYLCHOLINESTERASE; ETHIDIUM BROMIDE; MALONALDEHYDE; QUERCETIN; REACTIVE OXYGEN METABOLITE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORPUS STRIATUM; DEMYELINATION; ENZYME ACTIVITY; HIPPOCAMPUS; HISTOLOGY; HYPOTHALAMUS; LIPID PEROXIDATION; LOCOMOTION; MALE; MYELIN SHEATH; NEUROPROTECTION; NONHUMAN; PONS; RAT; REMYELINIZATION;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ACETYLCHOLINESTERASE; DEMYELINATION; LOCOMOTOR ACTIVITY; QUERCETIN; REMYELINATION;

ANIMALS; ANTIOXIDANTS; CHOLINERGIC NEURONS; DEMYELINATING DISEASES; ETHIDIUM; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; QUERCETIN; RANDOM ALLOCATION; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION;

EID: 84899948073     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.03.033     Document Type: Article

References (71)

1. F.H. Abdalla, A.M. Cardoso, L.B. Pereira, R. Schmatz, J.F. Goncalves, and N. Stefanello et al. Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats Mol Cell Biochem 381 2013 1 8
2. O.M. Abdel-Salam, Y.A. Khadrawy, N.A. Mohammed, and E.R. Youness The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain J Basic Clin Physiol Pharmacol 23 2012 61 68
3. C.F. Anhoque, S.C. Domingues, T. Carvalho, A.L. Teixeira, and R.B. Domingues Anxiety and depressive symptoms in clinically isolated syndrome and multiple sclerosis Arq Neuropsiquiatr 69 2011 882 886
4. M.A. Ansari, H.M. Abdul, G. Joshi, W.O. Opii, and D.A. Butterfield Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease J Nutr Biochem 20 2009 269 275
5. H.T. Besler, S. Comoglu, and Z. Okcu Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis Nutr Neurosci 5 2002 215 220
6. C. Bjartmar, J.R. Wujek, and B.D. Trapp Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease J Neurol Sci 206 2003 165 171
7. W.F. Blakemore Remyelination in the CNS Prog Clin Biol Res 59A 1981 105 109
8. A. Blokland Acetylcholine: a neurotransmitter for learning and memory? Brain Res Brain Res Rev 21 1995 285 300
9. E.F. Bondan, M.A. Lallo, I.L. Sinhorini, L.A. Pereira, and D.L. Graca The effect of cyclophosphamide on brainstem remyelination following local ethidium bromide injection in Wistar rats J Submicrosc Cytol Pathol 32 2000 603 612
10. E.F. Bondan, M.A. Lallo, M.L. Dagli, L.A. Pereira, and D.L. Graca Blood-brain barrier breakdown following gliotoxic drug injection in the brainstem of Wistar rats Arq Neuropsiquiatr 60 2002 582 589
11. E.F. Bondan, M.A. Lallo, H. Orsini, H.L. Bentubo, A. Yazbek, and D.J. Macrini et al. Evaluation of locomotor activity after a local induction of toxic demyelination in the brainstem of Wistar rats Arq Neuropsiquiatr 64 2006 496 503
12. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
13. J. Chakraborty, R. Singh, D. Dutta, A. Naskar, U. Rajamma, and K.P. Mohanakumar Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease CNS Neurosci Ther 20 2014 10 19
14. Z.Y. Chen, P.T. Chan, K.Y. Ho, K.P. Fung, and J. Wang Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups Chem Phys Lipids 79 1996 157 163
15. A. Das, M. Dikshit, and C. Nath Profile of acetylcholinesterase in brain areas of male and female rats of adult and old age Life Sci 68 2001 1545 1555
16. L. Descarries, V. Gisiger, and M. Steriade Diffuse transmission by acetylcholine in the CNS Prog Neurobiol 53 1997 603 625
17. S. Dhib-Jalbut, D.L. Arnold, D.W. Cleveland, M. Fisher, R.M. Friedlander, and M.M. Mouradian et al. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases J Neuroimmunol 176 2006 198 215
18. R. Dutta, J. McDonough, X. Yin, J. Peterson, A. Chang, and T. Torres et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients Ann Neurol 59 2006 478 489
19. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 95
20. M.G. Fehlings, and C.H. Tator The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury Exp Neurol 132 1995 220 228
21. G.D. Fulk Locomotor training and virtual reality-based balance training for an individual with multiple sclerosis: a case report J Neurol Phys Ther 29 2005 34 42
22. B. Giesser, J. Beres-Jones, A. Budovitch, E. Herlihy, and S. Harkema Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study Mult Scler 13 2007 224 231
23. D.L. Graca, and W.F. Blakemore Delayed remyelination in rat spinal cord following ethidium bromide injection Neuropathol Appl Neurobiol 12 1986 593 605
24. D.L. Graca, E.F. Bondan, L.A. Pereira, C.G. Fernandes, and P.C. Maiorka Behaviour of oligodendrocytes and Schwann cells in an experimental model of toxic demyelination of the central nervous system Arq Neuropsiquiatr 59 2001 358 361
25. J. Guimaraes, and M.J. Sa Cognitive dysfunction in multiple sclerosis Front Neurol 3 2012 74
26. T.D. Hernandez, and T. Schallert Seizures and recovery from experimental brain damage Exp Neurol 102 1988 318 324
27. M.G. Hertog, E.J. Feskens, P.C. Hollman, M.B. Katan, and D. Kromhout Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study Lancet 342 1993 1007 1011
28. P. Huebbe, A.E. Wagner, C. Boesch-Saadatmandi, F. Sellmer, S. Wolffram, and G. Rimbach Effect of dietary quercetin on brain quercetin levels and the expression of antioxidant and Alzheimer's disease relevant genes in mice Pharmacol Res 61 2010 242 246
29. A. Ishisaka, S. Ichikawa, H. Sakakibara, M.K. Piskula, T. Nakamura, and Y. Kato et al. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats Free Radic Biol Med 51 2011 1329 1336
30. N.D. Jeffery, and W.F. Blakemore Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination Brain 120 Pt. 1 1997 27 37
31. R. Jha, and S.I. Rizvi Age-dependent decline in erythrocyte acetylcholinesterase activity: correlation with oxidative stress Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 153 2009 195 198
32. P.J. Jongen, A.T. Ter Horst, and A.M. Brands Cognitive impairment in multiple sclerosis Minerva Med 103 2012 73 96
33. C.H. Kang, Y.H. Choi, S.K. Moon, W.J. Kim, and G.Y. Kim Quercetin inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-kappaB pathway and activating the Nrf2-dependent HO-1 pathway Int Immunopharmacol 17 2013 808 813
34. T.K. Kao, Y.C. Ou, S.L. Raung, C.Y. Lai, S.L. Liao, and C.J. Chen Inhibition of nitric oxide production by quercetin in endotoxin/cytokine- stimulated microglia Life Sci 86 2010 315 321
35. P. Knekt, R. Jarvinen, R. Seppanen, M. Hellovaara, L. Teppo, and E. Pukkala et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms Am J Epidemiol 146 1997 223 230
36. J. Lu, Y.L. Zheng, L. Luo, D.M. Wu, D.X. Sun, and Y.J. Feng Quercetin reverses d-galactose induced neurotoxicity in mouse brain Behav Brain Res 171 2006 251 260
37. R.M. Maciel, M.M. Costa, D.B. Martins, R.T. Franca, R. Schmatz, and D.L. Graca et al. Antioxidant and anti-inflammatory effects of quercetin in functional and morphological alterations in streptozotocin-induced diabetic rats Res Vet Sci 95 2013 389 397
38. C. Matute, and F. Perez-Cerda Multiple sclerosis: novel perspectives on newly forming lesions Trends Neurosci 28 2005 173 175
39. C. Matute, E. Alberdi, M. Domercq, F. Perez-Cerda, A. Perez-Samartin, and M.V. Sanchez-Gomez The link between excitotoxic oligodendroglial death and demyelinating diseases Trends Neurosci 24 2001 224 230
40. C.M. Mazzanti, R.M. Spanevello, A. Obregon, L.B. Pereira, C.A. Streher, and M. Ahmed et al. Ethidium bromide inhibits rat brain acetylcholinesterase activity in vitro Chem Biol Interact 162 2006 121 127
41. C.M. Mazzanti, R.M. Spanevello, L.B. Pereira, J.F. Goncalves, R. Kaizer, and M. Correa et al. Acetylcholinesterase activity in rats experimentally demyelinated with ethidium bromide and treated with interferon beta Neurochem Res 31 2006 1027 1034
42. C.M. Mazzanti, R. Spanevello, M. Ahmed, R. Schmatz, A. Mazzanti, and F.Z. Salbego et al. Cyclosporine A inhibits acetylcholinesterase activity in rats experimentally demyelinated with ethidium bromide Int J Dev Neurosci 25 2007 259 264
43. C.M. Mazzanti, R. Spanevello, M. Ahmed, L.B. Pereira, J.F. Goncalves, and M. Correa et al. Pre-treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents Int J Dev Neurosci 27 2009 73 80
44. E. Miller, M. Mrowicka, J. Saluk-Juszczak, and M. Ireneusz The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis Neurochem Res 36 2011 1012 1016
45. G. Minguetti Magnetic resonance imaging in multiple sclerosis: analysis of 270 cases Arq Neuropsiquiatr 59 2001 563 569
46. K. Mitosek-Szewczyk, W. Gordon-Krajcer, P. Walendzik, and Z. Stelmasiak Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy Folia Neuropathol 48 2010 116 122
47. M.F. Molina, I. Sanchez-Reus, I. Iglesias, and J. Benedi Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver Biol Pharm Bull 26 2003 1398 1402
48. O.G. Nilsson, and A. Bjorklund Behaviour-dependent changes in acetylcholine release in normal and graft-reinnervated hippocampus: evidence for host regulation of grafted cholinergic neurons Neuroscience 49 1992 33 44
49. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
50. A. Pajoohesh-Ganji, K.R. Byrnes, G. Fatemi, and A.I. Faden A combined scoring method to assess behavioral recovery after mouse spinal cord injury Neurosci Res 67 2010 117 125
51. M.M. Panjabi, and J.R. Wrathall Biomechanical analysis of experimental spinal cord injury and functional loss Spine 13 1988 1365 1370
52. J. Pelissier, C. Benaim, and S. Petiot Locomotor reeducation and multiple sclerosis. A critical analysis of the literature Rev Neurol 157 2001 1030 1040
53. J.A. Pereira, F. Lebrun-Julien, and U. Suter Molecular mechanisms regulating myelination in the peripheral nervous system Trends Neurosci 35 2012 123 134
54. L.K. Peterson, and R.S. Fujinami Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis J Neuroimmunol 184 2007 37 44
55. J. Porcel, and X. Montalban Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis J Neurol Sci 245 2006 177 181
56. P.G. Rendell, J.D. Henry, L.H. Phillips, X. de la Piedad Garcia, P. Booth, and P. Phillips et al. Prospective memory, emotional valence, and multiple sclerosis J Clin Exp Neuropsychol 34 7 2012 738 749
57. A.S. Rivlin, and C.H. Tator Objective clinical assessment of motor function after experimental spinal cord injury in the rat J Neurosurg 47 1977 577 581
58. J.B. Rocha, T. Emanuelli, and M.E. Pereira Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats Acta Neurobiol Exp 53 1993 431 437
59. J.I. Rossato, G. Zeni, C.F. Mello, M.A. Rubin, and J.B. Rocha Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat Neurosci Lett 318 2002 137 140
60. E.S. Sallis, C.M. Mazzanti, A. Mazzanti, L.A. Pereira, K.F. Arroteia, and R. Fustigatto et al. OSP-Immunofluorescent remyelinating oligodendrocytes in the brainstem of toxically-demyelinated Wistar rats Arq Neuropsiquiatr 64 2006 240 244
61. M. Skender-Gazibara, D. Cvetkovic-Dozic, V. Jovanvic, and S. Dozic Etiopathogenesis of multiple sclerosis Arq Neuropsiquiatr 2001 8 10
62. R.M. Spanevello, C.M. Mazzanti, P.A. Maldonado, R. Zanin, A. Morsch, and L. Hannel et al. Activities of enzymes that hydrolyze adenine nucleotides in platelets from rats experimentally demyelinated with ethidium bromide and treated with interferon-beta Life Sci 80 2007 1109 1114
63. R. Spanevello, C.M. Mazzanti, R. Schmatz, M. Bagatini, N. Stefanello, and M. Correa et al. Effect of vitamin E on ectonucleotidase activities in synaptosomes and platelets and parameters of oxidative stress in rats experimentally demyelinated Brain Res Bull 80 2009 45 51
64. J.P. Spencer, G.G. Kuhnle, R.J. Williams, and C. Rice-Evans Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites Biochem J 372 2003 173 181
65. J.P. Spencer, C. Rice-Evans, and R.J. Williams Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability J Biol Chem 278 2003 34783 34793
66. S. Sriram Role of glial cells in innate immunity and their role in CNS demyelination J Neuroimmunol 239 2011 13 20
67. Y. Wang, Z.Z. Zhang, Y. Wu, J.J. Ke, X.H. He, and Y.L. Wang Quercetin postconditioning attenuates myocardial ischemia/reperfusion injury in rats through the PI3K/Akt pathway Braz J Med Biol Res 46 2013 861 867
68. K. Yajima, and K. Suzuki Demyelination and remyelination in the rat central nervous system following ethidium bromide injection Lab Invest 41 1979 385 392
69. H. Yang, W.L. Jin, C.T. Wang, S.W. You, and G. Ju Expression and biological activity of human neurotrophin-3 in olfactory ensheathing cells mediated by retroviral vector Shi Yan Sheng Wu Xue Bao 36 2003 5 12
70. K.A. Youdim, M.S. Dobbie, G. Kuhnle, A.R. Proteggente, N.J. Abbott, and C. Rice-Evans Interaction between flavonoids and the blood-brain barrier: in vitro studies J Neurochem 85 2003 180 192
71. K.A. Youdim, M.Z. Qaiser, D.J. Begley, C.A. Rice-Evans, and N.J. Abbott Flavonoid permeability across an in situ model of the blood-brain barrier Free Radic Biol Med 36 2004 592 604